1-2 of 2
Robert Gagnon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B250: Clinical benefit of lapatinib‐based therapy in patients with HER2‐positive breast tumors expressing p95HER2

Maurizio Scaltriti, Sarat Chandarlapaty, Ludmila Prudkin, Claudia Aura, Jose Jimenez, Pierdavide Angelini, Cathrine Ellis, Robert Gagnon, Neil Rosen, Jose Baselga
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B250.
https://doi.org/10.1158/1535-7163.TARG-09-B250
Published: 10 December 2009
View article titled, Abstract B250: Clinical benefit of lapatinib‐based therapy in patients with HER2‐positive breast tumors expressing p95HER2
Journal Articles

Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles

Priti S. Hegde, David Rusnak, Melissa Bertiaux, Krystal Alligood, Jay Strum, Robert Gagnon, Tona M. Gilmer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1629–1640.
https://doi.org/10.1158/1535-7163.MCT-05-0399
Published: 18 May 2007
View article titled, Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Open the PDF for Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles in another window